These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38228164)

  • 21. [Detection of laboratory biomarkes in haematological and pulmonology patients at high risk for aspergillosis].
    Ratkov E; Vidović A; Minić P; Janić D; Šipetić-Grujičić S; Džamić A; Arsić-Arsenijević V
    Srp Arh Celok Lek; 2012; 140(5-6):290-8. PubMed ID: 22826981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary aspergillosis: a clinical review.
    Kousha M; Tadi R; Soubani AO
    Eur Respir Rev; 2011 Sep; 20(121):156-74. PubMed ID: 21881144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
    Otu AA; Langridge P; Denning DW
    Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?
    Barberan J; Alcazar B; Malmierca E; Garcia de la Llana F; Dorca J; Del Castillo D; Villena V; Hernandez-Febles M; Garcia-Perez FJ; Granizo JJ; Gimenez MJ; Aguilar L;
    BMC Infect Dis; 2012 Nov; 12():295. PubMed ID: 23145899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility and development of biomarkers in invasive aspergillosis.
    Patterson TF
    Trans Am Clin Climatol Assoc; 2011; 122():174-83. PubMed ID: 21686223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
    Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
    Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostics and susceptibility testing in Aspergillus.
    Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M
    Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary aspergillosis: diagnosis and treatment.
    Lamoth F; Calandra T
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36450372
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of LDBio
    Stucky Hunter E; Richardson MD; Denning DW
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31217272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal Resistance in Pulmonary Aspergillosis.
    Verweij PE; Song Y; Buil JB; Zhang J; Melchers WJG
    Semin Respir Crit Care Med; 2024 Feb; 45(1):32-40. PubMed ID: 38196063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aspergillus in airway material : Ignore or treat?].
    Salzer HJF; Lange C; Hönigl M
    Internist (Berl); 2017 Nov; 58(11):1150-1162. PubMed ID: 28986661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance.
    Izumikawa K; Takazono T; Kohno S
    Curr Opin Infect Dis; 2010 Dec; 23(6):584-9. PubMed ID: 20827190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Aspergillosis: What the Generalist Needs to Know.
    El-Baba F; Gao Y; Soubani AO
    Am J Med; 2020 Jun; 133(6):668-674. PubMed ID: 32240631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of azole resistant-
    Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
    J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
    [No Abstract]   [Full Text] [Related]  

  • 36. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
    Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
    J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis.
    Mei ZX; Han JF; Yu HW; Zhang Y; Ji P; Xie Y; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1081-1089. PubMed ID: 37453946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic aspergillosis of the respiratory tract.
    Shah A; Panjabi C
    Eur Respir Rev; 2014 Mar; 23(131):8-29. PubMed ID: 24591658
    [No Abstract]   [Full Text] [Related]  

  • 40. Endobronchial aspergilloma-a comprehensive literature review with focus on diagnosis and treatment modalities.
    Ngu S; Narula N; Abureesh M; Li JJ; Chalhoub M
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):601-605. PubMed ID: 31741102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.